Peter Bader Selected Research

Peter Bader Research Topics

Disease

47	Neoplasms (Cancer) 11/2021 - 11/2002
38	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 02/2003
29	Leukemia 01/2022 - 02/2003
25	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 05/2003
14	Residual Neoplasm 01/2022 - 01/2009
10	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 01/2004
10	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2021 - 11/2004
10	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2020 - 11/2011
8	Infections 12/2021 - 03/2015
6	Aplastic Anemia (Anemia, Hypoplastic) 01/2021 - 01/2005
5	Juvenile Myelomonocytic Leukemia 10/2020 - 02/2003
4	Disease Progression 03/2022 - 07/2008
4	Rhabdomyosarcoma 03/2021 - 09/2010
4	Cytopenia 01/2020 - 03/2005
4	Multiple Myeloma 01/2018 - 05/2003
3	Cytokine Release Syndrome 01/2022 - 01/2018
3	Ataxia Telangiectasia (Louis Bar Syndrome) 11/2021 - 01/2018
3	Osteonecrosis (Kienbock's Disease) 12/2020 - 10/2018
3	Communicable Diseases (Infectious Diseases) 06/2020 - 01/2020
3	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 12/2017
3	Bronchiolitis Obliterans Syndrome 01/2020 - 01/2018
3	Virus Diseases (Viral Diseases) 01/2019 - 03/2015
3	Neuroblastoma 01/2019 - 02/2010
3	Sarcoma (Soft Tissue Sarcoma) 01/2018 - 01/2012
3	Sepsis (Septicemia) 12/2016 - 02/2015
3	Ewing Sarcoma (Sarcoma, Ewing) 10/2016 - 01/2005
3	Lymphoma (Lymphomas) 01/2015 - 11/2004
2	Inflammation (Inflammations) 03/2022 - 09/2011
2	Leukocyte adhesion deficiency type 1 03/2022 - 12/2021
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2022 - 02/2003
2	Immune System Diseases (Immune Disorders) 01/2022 - 10/2019
2	Primary Immunodeficiency Diseases 12/2021 - 01/2018
2	Diamond-Blackfan Anemia (Anemia, Diamond Blackfan) 01/2021 - 01/2020
2	Pathologic Complete Response 01/2021 - 01/2019
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020 - 01/2018
2	Iron Overload 01/2020 - 12/2018
2	Hematologic Diseases (Blood Diseases) 01/2020 - 01/2020
2	Sickle Cell Anemia (Hemoglobin S Disease) 12/2019 - 01/2017
2	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 11/2002
2	Bacterial Infections (Bacterial Infection) 05/2015 - 02/2015
2	Viremia 03/2015 - 02/2015
2	Aspergillosis 06/2008 - 05/2006
2	Carcinoma (Carcinomatosis) 03/2005 - 06/2004
1	Reinfection 03/2022
1	COVID-19 01/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2022
1	Alveolar Rhabdomyosarcoma 01/2022
1	Hemorrhage 12/2021

Drug/Important Bio-Agent (IBA)

15	CytokinesIBA 03/2021 - 01/2004
11	Chimeric Antigen ReceptorsIBA 01/2022 - 10/2016
6	blinatumomabIBA 01/2022 - 12/2016
5	AntigensIBA 01/2021 - 08/2013
4	tisagenlecleucelIBA 01/2022 - 01/2018
4	LigandsIBA 11/2010 - 01/2004
3	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 11/2002
3	Pharmaceutical PreparationsIBA 01/2021 - 01/2016
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2020 - 05/2003
3	SteroidsIBA 01/2018 - 08/2011
3	Interleukin-2 (IL2)IBA 09/2011 - 02/2010
3	Cytostatic AgentsIBA 03/2006 - 11/2002
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2014
2	VaccinesIBA 01/2022 - 08/2013
2	Ferritins (Ferritin)IBA 08/2021 - 12/2018
2	Busulfan (Busulfex)FDA Link 01/2021 - 01/2017
2	treosulfanIBA 01/2021 - 10/2020
2	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 01/2021 - 10/2020
2	fludarabineIBA 01/2021 - 10/2020
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 05/2003
2	Carrier Proteins (Binding Protein)IBA 11/2019 - 09/2010
2	Biological ProductsIBA 11/2019 - 12/2016
2	interleukin-21 (interleukin 21)IBA 01/2019 - 01/2017
2	Interleukin-15 (Interleukin 15)IBA 01/2019 - 01/2012
2	AntibodiesIBA 01/2018 - 05/2004
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 08/2015
2	InterleukinsIBA 01/2017 - 01/2012
2	HLA Antigens (Human Leukocyte Antigens)IBA 05/2015 - 02/2015
2	Antiviral Agents (Antivirals)IBA 03/2015 - 03/2015
2	Interferon-gamma (Interferon, gamma)IBA 11/2011 - 02/2010
2	Vorinostat FDA Link 03/2006 - 03/2005
2	Histone Deacetylase InhibitorsIBA 03/2006 - 03/2005
2	Antineoplastic Agents (Antineoplastics)IBA 03/2006 - 11/2002
2	trichostatin A (A 300)IBA 03/2006 - 03/2005
2	Butyric Acid (Butanoic Acid)IBA 03/2006 - 03/2005
2	IsoenzymesIBA 06/2004 - 11/2002
2	Protein Kinase CIBA 06/2004 - 11/2002
2	Vincristine (Oncovin)FDA LinkGeneric 06/2004 - 11/2002
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 03/2022
1	IntegrinsIBA 03/2022
1	Immunoglobulin A (IgA)IBA 11/2021

Therapy/Procedure

57	Hematopoietic Stem Cell Transplantation 03/2022 - 01/2005
51	Stem Cell Transplantation 01/2021 - 05/2003
41	Transplantation 01/2022 - 02/2003
37	Therapeutics 01/2022 - 05/2004
13	Immunotherapy 03/2021 - 05/2004
7	Drug Therapy (Chemotherapy) 01/2021 - 05/2006
5	Cell Transplantation 01/2022 - 12/2015
4	Bone Marrow Transplantation (Transplantation, Bone Marrow) 04/2015 - 01/2004
3	Homologous Transplantation 04/2015 - 01/2009
3	Haploidentical Transplantation 06/2014 - 09/2004
2	Consolidation Chemotherapy 10/2016 - 11/2005